Sherwin-Williams (NYSE:SHW) PT Raised to $380.00 (2024)

Posted by ABMN Staff on Aug 30th, 2024

Sherwin-Williams (NYSE:SHW – Get Free Report) had its target price upped by equities researchers at Evercore ISI from $365.00 to $380.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the specialty chemicals company’s stock. Evercore ISI’s price objective would indicate a potential upside of 5.45% from the company’s current price.

SHW has been the topic of a number of other reports. Wells Fargo & Company raised their price objective on Sherwin-Williams from $320.00 to $350.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 24th. BMO Capital Markets raised their target price on Sherwin-Williams from $360.00 to $386.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Redburn Atlantic raised Sherwin-Williams to a “strong-buy” rating in a report on Thursday, July 18th. The Goldman Sachs Group raised their target price on Sherwin-Williams from $344.00 to $390.00 and gave the company a “buy” rating in a report on Wednesday, July 24th. Finally, Barclays lifted their price objective on Sherwin-Williams from $315.00 to $355.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 24th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Sherwin-Williams currently has an average rating of “Moderate Buy” and a consensus target price of $358.95.

View Our Latest Report on SHW

Sherwin-Williams Stock Down 0.4 %

Shares of SHW stock opened at $360.35 on Friday. The stock’s 50 day simple moving average is $330.10 and its 200 day simple moving average is $322.34. The company has a debt-to-equity ratio of 2.17, a quick ratio of 0.50 and a current ratio of 0.81. Sherwin-Williams has a twelve month low of $232.06 and a twelve month high of $363.15. The company has a market capitalization of $91.37 billion, a price-to-earnings ratio of 38.42, a PEG ratio of 2.79 and a beta of 1.16.

Sherwin-Williams (NYSE:SHW – Get Free Report) last issued its quarterly earnings data on Tuesday, July 23rd. The specialty chemicals company reported $3.70 earnings per share for the quarter, beating analysts’ consensus estimates of $3.51 by $0.19. Sherwin-Williams had a return on equity of 75.58% and a net margin of 10.92%. The business had revenue of $6.27 billion for the quarter, compared to the consensus estimate of $6.33 billion. During the same period last year, the business earned $3.29 EPS. The firm’s revenue was up .5% compared to the same quarter last year. As a group, research analysts predict that Sherwin-Williams will post 11.44 EPS for the current year.

Institutional Investors Weigh In On Sherwin-Williams

Institutional investors and hedge funds have recently made changes to their positions in the company. New Century Financial Group LLC grew its stake in shares of Sherwin-Williams by 17.1% during the second quarter. New Century Financial Group LLC now owns 885 shares of the specialty chemicals company’s stock worth $264,000 after purchasing an additional 129 shares during the period. Cetera Investment Advisers grew its stake in shares of Sherwin-Williams by 1.3% during the second quarter. Cetera Investment Advisers now owns 57,433 shares of the specialty chemicals company’s stock worth $17,140,000 after purchasing an additional 742 shares during the period. Ted Buchan & Co acquired a new stake in shares of Sherwin-Williams during the second quarter worth $267,000. Advisory Alpha LLC grew its stake in shares of Sherwin-Williams by 0.6% during the second quarter. Advisory Alpha LLC now owns 5,585 shares of the specialty chemicals company’s stock worth $1,667,000 after purchasing an additional 36 shares during the period. Finally, Truist Financial Corp grew its stake in shares of Sherwin-Williams by 0.9% during the second quarter. Truist Financial Corp now owns 52,204 shares of the specialty chemicals company’s stock worth $15,579,000 after purchasing an additional 446 shares during the period. Institutional investors own 77.67% of the company’s stock.